Collaborators

The RECONS Study is a global partnership dedicated to improving outcomes in reconstructive orthopaedic surgery—especially for people undergoing lower limb lengthening and deformity correction. Our mission is to move beyond traditional ways of measuring success (like X-rays or technical measures) and focus on what truly matters to patients in their everyday lives.

Our Core Network Partners

Our core partners include leading hospitals, institutes, and universities from four continents:

  • 🇩🇰 Denmark: Department of Orthopaedics, Aalborg University Hospital
    Coordinator and scientific lead of the RECONS network. Internationally recognized for expertise in orthopaedic reconstruction, Core Outcome Set (COS) development, and patient-centred research methodology.
    Aalborg University Hospital

  • 🇺🇸 USA: Department of Orthopedics, Nationwide Children’s Hospital, Columbus, OH
    Clinical partner and global leader in limb lengthening and deformity correction.
    Nationwide Children’s Hospital

  • 🇰🇷 South Korea: Donghoon Advanced Lengthening Reconstruction Institute, Seoul
    Centre of excellence in advanced limb reconstruction. Pioneers in surgical innovation and long-term follow-up care.
    Donghoon Institute

  • 🇿🇦 South Africa: Institute of Orthopaedics and Rheumatology, Stellenbosch
    Leading African centre for orthopaedic surgery and public health integration. Brings essential insight into outcome measurement in diverse healthcare settings.
    IOR Health

Our International Collaborators

Alongside our core partners, the RECONS Study brings together collaborators, researchers, and study participants from over 20 countries, including:

🇦🇹 Austria 🇧🇷 Brazil 🇨🇦 Canada 🇩🇰 Denmark 🇫🇮 Finland 🇫🇷 France 🇩🇪 Germany 🇮🇱 Israel 🇳🇴 Norway 🇵🇱 Poland 🇵🇹 Portugal 🇷🇺 Russia 🇷🇸 Serbia 🇿🇦 South Africa 🇪🇸 Spain 🇸🇪 Sweden 🇨🇭 Switzerland 🇹🇷 Türkiye 🇬🇧 United Kingdom 🇺🇸 United States

This global network allows us to develop, test, and implement the COS that are meaningful and relevant across different cultures, health systems, and patient populations.

Why This Matters

By working together, our network is setting new standards for how success is defined in reconstructive orthopaedics—not just by what is seen on a scan, but by what is felt and valued by patients and their families. Our collaboration means:

  • Standardizing what outcomes to measure so studies can be compared worldwide

  • Listening to patients, caregivers, and professionals to define what really matters

  • Bringing together clinicians, researchers, engineers, and innovators to create practical tools for better care and research